Find the value.
Skip the noise.
My Screeners
No screeners
System Screeners
My Watchlists
No watchlists
System Watchlists
My Screeners
No screeners
System Screeners
My Watchlists
No watchlists
System Watchlists
Loading...
T. Rowe Price Biotech ETF operates as an actively managed equity strategy focused primarily on biotechnology companies. Its objective is long-term capital growth through the identification of firms advancing innovative technologies that have the potential to treat or cure disease and improve quality of human life. The fund emphasizes fundamental, bottom-up research and analysis in selecting stocks.
Under normal market conditions the majority of assets are invested in common stocks, with a policy to concentrate over 25 % of its net assets in biotechnology companies. While most holdings are U.S.-domiciled, the fund may also include foreign biotech equities that align with its innovation-oriented objective. It may invest in companies of any market capitalization.
The fund is offered by T. Rowe Price, structured as an exchange-traded fund under U.S. regulatory oversight. Shares trade on a national securities exchange.
Click to see warnings
This share class is accumulating: income is reinvested, and no cash dividends are paid.
Log in to see details
Log in for full accessIt is important that you understand how Findx arrives at Fair Value. Please take a minute to watch this short explainer.
It is very important that you understand this
Fair Value is an estimate, and you choose the basis it is built on. Do not invest based on our default without understanding how we calculate it.
